Study Details
A study to evaluate the efficacy and safety of ASP4901 in patients with benign prostate hyperplasia
This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).
Clinicaltrials.gov ID
The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
Astellas Study ID
The unique identification code given by the study sponsor.
4901-CL-0201
EudraCT ID
The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).
N/A
Condition
Enlarged Prostate
Phase
These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.
Phase 2
Age
40 years - 74 years
Sex
Male
Product
N/A
Type
A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
Interventional
Trial Dates
Jul 2013 - Apr 2014
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
320
Double-Blind, Placebo-Controlled, Active-Referenced, Parallel-Group Comparative Study in Patients with Benign Prostatic Hyperplasia
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate the efficacy and safety of ASP4901 in patients with benign prostate hyperplasia? Contact us by filling our your information to the right and we’ll respond to you.